← FDA Drug Approvals (Drugs@FDA)

DAPAGLIFLOZIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CENTAUR PHARMACEUTICALS PRIVATE LIMITED · Approved 2026-05-06

Drug application

FDA Application #

ANDA220679

Application type

Abbreviated New Drug Application (Generic)

Brand name

DAPAGLIFLOZIN

Generic name

Dapagliflozin

Active ingredients

DAPAGLIFLOZIN

Dosage form

TABLET

Route

—

Marketing status

None (Tentative Approval)

Sponsor

CENTAUR PHARMACEUTICALS PRIVATE LIMITED

First approval

2026-05-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown